[go: up one dir, main page]

DK518187A - Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr - Google Patents

Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr

Info

Publication number
DK518187A
DK518187A DK518187A DK518187A DK518187A DK 518187 A DK518187 A DK 518187A DK 518187 A DK518187 A DK 518187A DK 518187 A DK518187 A DK 518187A DK 518187 A DK518187 A DK 518187A
Authority
DK
Denmark
Prior art keywords
stimulating
mammal
procedure
pharmaceutical preparation
melamine production
Prior art date
Application number
DK518187A
Other languages
English (en)
Other versions
DK518187D0 (da
Inventor
Victor J Hruby
Mac E Hadley
Robert Dorr
Norman Levine
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of DK518187D0 publication Critical patent/DK518187D0/da
Publication of DK518187A publication Critical patent/DK518187A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK518187A 1986-02-03 1987-10-02 Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr DK518187A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82516286A 1986-02-03 1986-02-03
PCT/US1987/000226 WO1987004623A1 (en) 1986-02-03 1987-01-23 Method of stimulating melanocytes by topical application of analogs of alpha-msh, and compositions for use in same

Publications (2)

Publication Number Publication Date
DK518187D0 DK518187D0 (da) 1987-10-02
DK518187A true DK518187A (da) 1987-12-02

Family

ID=25243274

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518187A DK518187A (da) 1986-02-03 1987-10-02 Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr

Country Status (11)

Country Link
US (2) US4918055A (da)
EP (1) EP0259440B1 (da)
KR (1) KR900005903B1 (da)
AT (1) ATE84420T1 (da)
AU (1) AU597630B2 (da)
CA (1) CA1282324C (da)
DE (1) DE3783541T2 (da)
DK (1) DK518187A (da)
IE (1) IE60883B1 (da)
NZ (1) NZ233248A (da)
WO (1) WO1987004623A1 (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2711549B2 (ja) * 1987-06-01 1998-02-10 圭吉 杉山 白髪防止・改善用組成物
US5049547A (en) * 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
US4874744A (en) * 1989-03-13 1989-10-17 University Of Cincinnati Method of using melanocyte stimulating hormone as dermatis treatment
EP0389950A1 (en) * 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5420109A (en) * 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US6001812A (en) * 1995-04-28 1999-12-14 Societe L'oreal S.A. Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone
FR2733421B1 (fr) * 1995-04-28 1997-06-06 Oreal Utilisation de derives de l'hormone stimulatrice des melanocytes de type alpha pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US5767152A (en) * 1995-05-04 1998-06-16 Nielsen; Thor Bagger Composition and methods for stimulating hair growth
US6696417B1 (en) 1997-11-21 2004-02-24 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin and hair darkening composition
GB9801191D0 (en) * 1998-01-20 1998-03-18 Unilever Plc Skin and hair darkening composition
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
DE60029304T2 (de) * 1999-01-22 2007-07-05 The Schepens Eye Research Institute, Inc., Boston Aktivierung von regulatorischen t zellen durch ein alpha-melanocyten stimulierendes hormon
HK1044287A1 (zh) * 1999-03-24 2002-10-18 Zengen, Inc. 源自刺激α-黑素细胞激素的抗菌氨基酸序列
US6800291B1 (en) * 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
US7402559B2 (en) 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
US20050142078A1 (en) * 2002-02-26 2005-06-30 Dorr Robert T. Method of stimulation of melanin production and induction of skin tanning
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
WO2005048967A1 (en) * 2003-11-24 2005-06-02 Clinuvel Pharmaceuticals Limited A method of inducing melanogenesis in humans with mc1r variant alleles
CN101076314A (zh) * 2004-08-04 2007-11-21 克里纽沃药物有限公司 在对象体内诱导黑素生成的方法
NZ554427A (en) * 2004-10-08 2010-09-30 Clinuvel Pharmaceuticals Ltd Compositions and methods for inducing melanogenesis in a subject utilising afamelanotide
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
EP1814574A4 (en) 2004-10-27 2009-08-05 Univ Denver ANALOGUE OF ADRENOCORTICOTROPEN HORMON AND CORRESPONDING METHODS
WO2008015342A2 (fr) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
AU2007291943B2 (en) * 2006-08-28 2013-11-14 Clinuvel Pharmaceuticals Limited Method for reducing incidence or rate of development of skin cancers and related conditions
SI2865422T1 (sl) 2006-08-31 2017-12-29 Clinuvel Pharmaceuticals Limited Alfa-MSH derivati za zdravljenje fotodermatoz
CA2666418A1 (en) * 2006-10-13 2008-05-29 Reliance Life Sciences Pvt. Ltd. Cultured melanocytes on biopolymers
DK2957292T3 (da) * 2008-03-27 2018-01-22 Clinuvel Pharmaceuticals Ltd Vitiligoterapi
US8338565B2 (en) 2008-08-20 2012-12-25 Ensemble Therapeutics Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
US9402877B2 (en) 2011-11-04 2016-08-02 Xion Pharmaceuticals Corporation Methods and compositions for oral administration of melanocortin receptor agonist compounds
WO2013135880A1 (en) * 2012-03-15 2013-09-19 Galderma Research & Development Combination of a mc1r receptor agonist and uvb for the treatment and/or prevention of pigmentation disorders
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271742A1 (en) * 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Skin tanning using peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
WO2015063099A1 (en) 2013-10-28 2015-05-07 Clinuvel Ag Alpha-msh analogues for use in the treatment of hailey-hailey disease
WO2015063102A1 (en) 2013-10-28 2015-05-07 Clinuvel Ag Alpha-msh analogues for use in bullous disease
WO2015067503A1 (en) 2013-11-07 2015-05-14 Clinuvel Ag Alpha-msh analogues for use in the treatment of psoriasis
EP3197920B1 (en) 2014-09-25 2021-01-13 Nanyang Technological University Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
EP3212219A1 (en) 2014-10-28 2017-09-06 Clinuvel AG New indication for alpha-msh analogues
US20170360896A1 (en) 2014-10-28 2017-12-21 Clinuvel Ag Inflammatory disease
WO2016195476A1 (en) 2015-05-29 2016-12-08 Erasmus University Medical Center Rotterdam Treatment of cardiac arrhythmias
CN106265134B (zh) * 2016-03-17 2019-02-19 哈尔滨源茂达生物技术有限公司 一种多肽美白修复精华液及其制备方法
CA3050630A1 (en) 2017-02-01 2018-08-09 Clinuvel Pharmaceuticals Ltd Alpha-msh analogues used in the treatment of xeroderma pigmentosum
WO2025253347A1 (en) * 2024-06-07 2025-12-11 Vimela Therapeutics, Inc. Topical delivery of melanocortin-1 receptor agonists formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2158123A1 (de) * 1970-12-02 1972-06-08 Ciba-Geigy Ag, Basel (Schweiz) Neue pharmazeutische Präparate
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin
DE3623019A1 (de) * 1986-07-09 1988-01-21 Dieter Prof Dr Dr Aderhold Melanotropin als therapeutischer wirkstoff

Also Published As

Publication number Publication date
WO1987004623A1 (en) 1987-08-13
EP0259440A4 (en) 1989-11-07
AU7082887A (en) 1987-08-25
DE3783541D1 (de) 1993-02-25
KR900005903B1 (ko) 1990-08-16
DE3783541T2 (de) 1993-06-17
AU597630B2 (en) 1990-06-07
KR880700670A (ko) 1988-04-11
DK518187D0 (da) 1987-10-02
IE870236L (en) 1987-08-03
CA1282324C (en) 1991-04-02
IE60883B1 (en) 1994-08-24
EP0259440A1 (en) 1988-03-16
EP0259440B1 (en) 1993-01-13
US4918055A (en) 1990-04-17
NZ233248A (en) 1993-01-27
US4866038A (en) 1989-09-12
ATE84420T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
DK518187D0 (da) Fremgangsmaade og farmaceutisk praeparat til stimulering af melaminproduktionen i et pattedyr
DK634787D0 (da) Topiske farmaceutiske praeparater til behandling af acne
DK211981A (da) Hidtil ukendte sulfaterede polysaccharider fremgangsmaader til deres fremstilling og deres anvendelse som medikamenter
DK285488D0 (da) Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes
IT1140040B (it) Derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia
IT1205978B (it) Derivati di dicloroanilina,composizioni farmaceutiche che li contengono e procedimento per produrli
IT8219502A0 (it) Nuovi derivati della furo-(3,4-c)-piridina, procedimento per prepararli e composizioni terapeutiche che li contengono.
DK279890A (da) Liposom-indkapslede vincaalkaloider og anvendelse heraf til fremstilling af et laegemiddel til bekaempelse af tumorer
DK132790A (da) Antiinflammatoriske og analgetiske forbindelser, praeparater deraf og metoder til fremstilling og anvendelse deraf
DK218985A (da) Aminocyklopentylaetere, farmaceutiske praeparater indeholdende dem og fremgangsmaade til fremstilling af dem
DK355387A (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
IT7921922A0 (it) Procedimento per la determinazione dell'attivita' della colinesterasi e derivati della colina che vengono impiegati nel procedimento.
DK0739354T3 (da) Præparater og fremgangsmåder, hvor der anvendes ikke-bundet MPL-receptor til stimulering af blodpladeproduktion
DK651087A (da) Renininhibitorer iii, deres fremstilling og anvendelse
NO870210L (no) Fremgangsmaate og anordning for avskinning.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO895049D0 (no) Fremgangsmaate for tilvirkning av polyorganosiloksan og ensammensetning som er utherdbar med straaling.
DK506183A (da) Hidtil ukendte carbacykliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
IT1222154B (it) Derivati della taurina
DK72288D0 (da) Farmaceutisk praeparat til behandling af ulcerativ tyktarmssygdom
DK180290A (da) Monoxidil-gel og fremgangsmaade til fremstilling deraf
DK674587A (da) Anti-forkoelelses-kit, anti-forkoelelsespraeparat og anvendelse deraf
DK300381A (da) Hidtil ukendte 8alfa-oestra-1,3,5 (10)-trienderivater fremganggsmaader til deres fremstilling og farmaceutiske midler
IT1211683B (it) Derivati di isochinolina, composizioni che li contengono e procedimento per prepararli ed applicarli
DK74287D0 (da) Fremgangsmaade til alkoholisk gaering med gaer, hidtil ukendt gaer og anvendelse deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment